Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice

Cancer Research

Volumn 66, Issue 5, 2006, Pages 2536-2543

  Fedele, Monica ^a,h   Fidanza, Vincenzo ^h   Battista, Sabrina ^a,h   Pentimalli, Francesca ^a,h   Klein Szanto, Andres J P ⁱ   Visone, Rosa ^a   De Martino, Ivana ^a   Curcio, Antonio ^f   Morisco, Carmine ^b   Del Vecchio, Luigi ^c   Baldassarre, Gustavo ^h   Arra, Claudio ^d   Viglietto, Giuseppe ^a   Indolfi, Ciro ^f   Croce, Carlo M ^g   Fusco, Alfredo ^a,b,e  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c CARDARELLI HOSPITAL   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^f UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^g THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^h THOMAS JEFFERSON UNIVERSITY   (United States)

ⁱ FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A1A PROTEIN; HIGH MOBILITY GROUP A1B PROTEIN; LUCIFERASE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CELL DEATH; CHROMATIN; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENE TARGETING; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HISTOLOGY; HMGA1 GENE; IMMUNOGLOBULIN GENE; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 33645052445     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-1889     Document Type: TB

References (35)

1. Fedele M, Battista S, Manfioletti G, Croce CM, Giancotti V, Fusco A. Role of the high mobility group A proteins in human lipomas. Carcinogenesis 2001;22:1583-91.
2. Thanos D, Maniatis T. Virus induction of human IFN β gene expression requires the assembly of an enhanceosome. Cell 1995;83:1091-100.
3. Chiappetta G, Avantaggiato V, Visconti R, et al. High level expression of the HMGI (Y) gene during embryonic development. Oncogene 1996;13:2439-46.
4. Zhou X, Benson KF, Ashar HR, Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 1995; 376:771-4.
5. Battista S, Fidanza V, Fedele M, et al. The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res 1999;59:4793-7.
6. Melillo RM, Pierantoni GM, Scala S, et al. Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. Mol Cell Biol 2001;21:2485-95.
7. Tallini G, Dal Cin P. HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors. Adv Anat Pathol 1999;6:237-46.
8. Berlingieri MT, Pierantoni GM, Giancotti V, Santoro M, Fusco A. Thyroid cell transformation requires the expression of the HMGA1 proteins. Oncogene 2002;21:2971-80.
9. Scala S, Portella G, Fedele M, Chiappetta G, Fusco A. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias. Proc Natl Acad Sci U S A 2000; 97:4256-61.
10. Fedele M, Berlingieri MT, Scala S, et al. Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts. Oncogene 1998;17:413-8.
11. Wood LJ, Maher JF, Bunton TE, Resar LM. The oncogenic properties of the HMG-I gene family. Cancer Res 2000;60:4256-61.
12. Baldassarre G, Fedele M, Battista S, et al. Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc Natl Acad Sci U S A 2001;98:7970-5.
13. Xu Y, Sumter TF, Bhattacharya R, et al. The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia. Cancer Res 2004;64:3371-5.
14. Fedele M, Pentimalli F, Baldassarre G, et al. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. Oncogene 2005;24:3427-35.
15. Fedele M, Battista S, Kenyon L, et al. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene 2002;21:3190-8.
16. Aoki H, Izumo S, Sadoshima J. Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin H-induced premyofibril formation. Circ Res 1998;81:666-76.
17. Ito H, Hiroe M, Hirata Y, et al. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 1993;87:1715-21.
18. Sadoshima J, Jahn L, Takahashi T, Kulik TJ, Izumo S. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J Biol Chem 1992;267:10551-60.
19. Battista S, Pentimalli F, Baldassarre G, et al. Loss of Hmga1 gene function affects embryonic stem cell lympho-hematopoietic differentiation. FASEB J 2003;17:1496-8.
20. Bichi R, Shinton SA, Martin ES, et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A 2002;99:6955-60.
21. Zhang T, Johnson EN, Gu Y, et al. The cardiac-specific nuclear δ(B) isoform of Ca2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity. J Biol Chem 2002; 277:1261-7.
22. Pennica D, King KL, Shaw KJ, et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci USA 1995;92:1142-6.
23. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999;79:215-62.
24. Masciullo V, Baldassarre G, Pentimalli F, et al. HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas. Carcinogenesis 2003; 24:1191-8.
25. Morse HC III, Anver MR, Fredrickson TN, et al. Bethesda proposal for classification of lymphoid neoplasms in mice. Blood 2002;100:246-58.
26. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996;381:751-8.
27. Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 2000;102:470-9.
28. Zapata JM, Krajewska M, Morse HC III, et al. TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice. Proc Natl Acad Sci U S A 2004;101:16600-5.
29. Katsumata M, Siegel RM, Louie DC, et al. Differential effects of Bcl-2 on T and B cells in transgenic mice. Proc Natl Acad Sci U S A 1992;89:11376-80.
30. Shannon MF, Himes SR, Attema J. A role for the architectural transcription factors HMGI(Y) in cytokine gene transcription in T cells. Immunol Cell Biol 1998;76:461-6.
31. Himes SR, Reeves R, Attema J, Nissen M, Li Y, Shannon MF. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation. J Immunol 2000;164:3157-68.
32. John S, Reeves RB, Lin JX, et al. Regulation of cell-type-specific interleukin-2 receptor α-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-κB family proteins. Mol Cell Biol 1995;15:1786-96.
33. Lee GS, Neiditch MB, Salus SS, Roth DB. RAG proteins shepherd double-strand breaks to a specific pathway. Suppressing error-prone repair, but RAG nicking initiates homologous recombination. Cell 2004; 117:171-84.
34. Zhu C, Mills KD, Ferguson DO, et al. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 2002; 109:811-21.
35. Martinez Hoyos J, Fedele M, Battista S, et al. Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulation. Cancer Res 2004;64:5728-35.